News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Danish Drug Maker Santaris Pharma A/S Considers U.S. Listing



3/27/2014 7:18:12 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Danish venture capital firm Sunstone is considering whether to list its partly owned biotech company Santaris Pharma in the United States, and will probably make a decision this year, Sunstone told Reuters on Wednesday. Santaris, which was founded through a merger of two companies in 2003, develops drugs against liver cancer, head and neck cancer, and against metabolic and infectious diseases. In 2006, Sunstone was the lead investor in a 45 million euro ($62.00 million) venture investment in Santaris and is now the main owner with a 24.8 percent stake, around twice as much as the next two owners, pension fund LD and industrial foundation Novo A/S.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES